Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $1130.0000 (-10.67%) ($1130.0000 - $1375.0000) on Tue. Oct. 21, 2008. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.43% (three month average) | RSI | 29 | Latest Price | $1130.0000(-10.67%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -5.3% a day on average for past five trading days. | Weekly Trend | CAPR declines -16.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(3%) EWP(2%) IWM(2%) USO(2%) XOP(2%) | Factors Impacting CAPR price | CAPR will decline at least -3.215% in a week (0% probabilities). EWY(-1%) XLU(0%) XLP(0%) VWO(-0%) TLT(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.215% (StdDev 6.43%) | Hourly BBV | 0 () | Intraday Trend | -17.8% | | | |
|
Resistance Level | $1613.43 | 5 Day Moving Average | $1324(-14.65%) | 10 Day Moving Average | $1297.86(-12.93%) | 20 Day Moving Average | $1613.43(-29.96%) | To recent high | -55.7% | To recent low | 0.4% | Market Cap | $22.258b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |